arginine has been researched along with Polycystic Ovary Syndrome in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (36.96) | 29.6817 |
| 2010's | 26 (56.52) | 24.3611 |
| 2020's | 3 (6.52) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, RE; Coolen, LM; Jamieson, BB; Lehman, MN; Lohr, DB; Moore, AM; Piet, R; Thomas, SX | 1 |
| Gao, H; Li, T; Liu, R; Wang, H; Yin, C; Zhang, Q; Zhang, T | 1 |
| Alipoor, E; Asghari, S; Hosseinzadeh-Attar, MJ; Mohammad Hosseinzadeh, F; Rashidi, BH; Yekaninejad, MS | 1 |
| Javn, SB; Loganathan, S; Mala, K; Ramachandran, S; Sundari, M; Thomas, S | 1 |
| Dsilva, B; Joseph, A; Krishna, MB; Laloraya, M; Pillai, SM; Thomas, PL | 1 |
| Dornauf, I; Fleming, I; Hinrichsmeyer, H; Kyselova, A; Mann, AW; Randriamboavonjy, V; Zukunft, S | 1 |
| Abdel-Hamid, HA; Ragy, MM; Toni, NDM | 1 |
| Chan, WP; Chirkov, YY; Heresztyn, T; Horowitz, JD; Ngo, DT; Rajendran, S; Stafford, I; Sverdlov, AL | 1 |
| Akdeniz, D; Carlioglu, A; Gumus, II; Karakurt, F; Kaygusuz, I; Uz, B | 1 |
| Bayraktar, N; Göktaş, T; Gülcan Kurt, Y; Güler, İ; Hımmetoğlu, MÖ; Kiliç, N; Taner, MZ; Taşlipinar, A; Yaman, H; Yavuz Taşlipinar, M | 1 |
| Hutchison, SK; McGrath, BP; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S | 1 |
| Chan, WP; Heresztyn, T; Horowitz, JD; Liberts, EA; Marber, MS; Norman, RJ; Rajendran, S; Saha, M; Willoughby, SR | 1 |
| Ciftci, O; Demirag, NG; Ertugrul, D; Kulaksizoglu, M; Kulaksizoglu, S; Pamuk, BO; Torun, AN; Yildirim, E | 1 |
| Acién, P | 1 |
| Verit, FF; Vural, M | 1 |
| Bruno, GA; Dinatale, S; Ghigo, E; Manieri, C; Martina, V; Masha, A | 1 |
| Christopoulos, P; Creatsas, G; Deligeoroglou, E; Diamanti-Kandarakis, E; Gazouli, M; Katsikis, I; Mastorakos, G; Panidis, D | 1 |
| Artini, PG; Battaglia, B; Battaglia, C; Facchinetti, F; Mancini, F; Venturoli, S | 1 |
| Engin-Üstün, Y; Kafkasli, A; Kali, Z; Karabulut, AB; Meydanli, M; Turan, F; Türkçüoğlu, I | 1 |
| Aydin, M; Batioglu, S; Erdogan, G; Kilic, S; Yilmaz, N; Zulfikaroglu, E | 1 |
| Bayrak, A; Bayrak, T; Cakir, E; Noyan, V; Sagsoz, N; Soyman, Z; Tulmac, M; Yucel, A | 1 |
| He, L; Li, Q; Sang, Q; Shi, J; Wang, H; Wang, L; Wang, T; Wang, Y; Xing, Q; Yang, G; Zhang, X; Zhao, X | 1 |
| Fu, L; Liu, N; Ma, Y; Qiao, J; Tu, B; Yan, L; Zhang, Q; Zhang, X | 1 |
| Adali, E; Bugdayci, G; Ilhan, GA; Kolusari, A; Yildizhan, B; Yildizhan, R | 1 |
| Cameron, JD; Moran, LJ; Strauss, BJ; Teede, HJ | 1 |
| Barry, JA; Hardiman, PJ; Kay, AR; Lakhani, K; Leiper, J | 1 |
| Bai, H; Fan, P; Liu, H; Wang, Y; Zhang, F; Zhang, J | 1 |
| Ma, J; Ruan, Y; Xie, X | 1 |
| Brinkworth, GD; Buckley, JD; Clifton, PM; Noakes, M; Norman, RJ; Thomson, RL | 1 |
| Bayrak, A; Bayrak, T; Cakır, E; Dursun, P; Gültekin, M; Kolusarı, A; Ozyurt, M; Zeyneloğlu, HB | 1 |
| Cho, S; Choi, YS; Jeon, YE; Jung, JA; Kim, HY; Lee, BS; Seo, SK; Yang, HI | 1 |
| Clifton, PM; Moran, LJ; Noakes, M; Norman, RJ; Wittert, GA | 1 |
| Balen, AH; Campbell, BK; Hemmings, KE; Hogg, JE; Leese, HJ; Maruthini, D; Picton, HM; Vyjayanthi, S | 1 |
| Castello, R; Escobar-Morreale, HF; Moghetti, P; Peral, B; San Millán, JL | 1 |
| Colao, A; Dentico, C; Lombardi, G; Nappi, C; Orio, F; Palomba, S; Russo, T; Savastano, S; Sultan, C; Tauchmanovà, L; Zullo, F | 1 |
| Angel, B; Maliqueo, M; Pérez-Bravo, F; Riesco, MV; Santos, JL; Sir-Petermann, T; Toloza, H | 1 |
| Aktas, A; Dilek, S; Erdal, EM; Ertunc, D; Tok, EC | 2 |
| Gong, KB; Ku, DC; Kuo, TC; Liang, SF; Lin, TC; Wu, MJ; Yen, JM | 1 |
| Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V | 1 |
| Biberoğlu, G; Bideci, A; Camurdan, MO; Cinaz, P; Demirel, F; Hasanoğlu, A; Yesilkaya, E | 1 |
| Dvořáková, K; Grimmichová, T; Hill, M; Stanická, S; Vondra, K; Vrbíková, J | 1 |
| Heutling, D; Kaltwasser, P; Kleinstein, J; Krzyzanowska, K; Lehnert, H; Mittermayer, F; Nickel, I; Randeva, H; Schernthaner, G; Schulz, H; Westphal, S; Wolzt, M | 1 |
| Nelson, SM; Sattar, N | 1 |
| Barrenechea, C; Cerda, A; Kehr, M; Salazar, LA; Soto, C; Valdés, P | 1 |
| Baser, I; Dede, M; Erbil, MK; Kenar, L; Oktenli, C; Ozgurtas, T; Sanisoglu, SY; Tapan, S; Yenen, MC; Yesilova, Z | 1 |
3 review(s) available for arginine and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Homocysteine; Humans; Oxidative Stress; Polycystic Ovary Syndrome; Receptor for Advanced Glycation End Products; von Willebrand Factor | 2017 |
Pathophysiological changes in experimental polycystic ovary syndrome in female albino rats: Using either hemin or L-arginine.
Topics: Animals; Arginine; Aromatase Inhibitors; Body Weight; Female; Gasotransmitters; Hemin; Humans; Letrozole; Oxidative Stress; Polycystic Ovary Syndrome; Rats | 2019 |
Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis.
Topics: Amino Acid Substitution; Arginine; Aspartic Acid; Case-Control Studies; Female; Gene Frequency; Genotype; Geography; Glycine; Humans; Insulin Receptor Substrate Proteins; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide | 2012 |
8 trial(s) available for arginine and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Effects of Selenium Supplementation on Asymmetric Dimethylarginine and Cardiometabolic Risk Factors in Patients with Polycystic Ovary Syndrome.
Topics: Adolescent; Adult; Arginine; Cardiometabolic Risk Factors; Dietary Supplements; Double-Blind Method; Female; Humans; Middle Aged; Polycystic Ovary Syndrome; Selenium; Testosterone; Young Adult | 2020 |
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor | 2010 |
L-arginine plus drospirenone-ethinyl estradiol in the treatment of patients with PCOS: a prospective, placebo controlled, randomised, pilot study.
Topics: Adult; Androstenedione; Androstenes; Arginine; Blood Flow Velocity; Brachial Artery; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovary; Pilot Projects; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography, Doppler, Color; Uterus; Young Adult | 2010 |
Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Contraceptives, Oral; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Young Adult | 2011 |
Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.
Topics: Adult; Arginine; Biomarkers; Female; Humans; Leptin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Retinol-Binding Proteins, Plasma; Young Adult | 2011 |
The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Diet; Endothelium, Vascular; Exercise; Exercise Therapy; Female; Humans; Insulin Resistance; Intercellular Adhesion Molecule-1; Overweight; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Risk; Vascular Cell Adhesion Molecule-1 | 2012 |
Association of Gly972Arg variant of insulin receptor substrate-1 with metabolic features in women with polycystic ovary syndrome.
Topics: Analysis of Variance; Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Female; Genetic Variation; Glycine; Humans; Insulin; Insulin Receptor Substrate Proteins; Phosphoproteins; Polycystic Ovary Syndrome | 2005 |
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome | 2008 |
35 other study(ies) available for arginine and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Prenatal androgen treatment impairs the suprachiasmatic nucleus arginine-vasopressin to kisspeptin neuron circuit in female mice.
Topics: Androgens; Animals; Arginine; Arginine Vasopressin; Female; Gonadotropin-Releasing Hormone; Humans; Kisspeptins; Luteinizing Hormone; Mice; Neurons; Polycystic Ovary Syndrome; Pregnancy; Suprachiasmatic Nucleus; Vasopressins | 2022 |
The ADMA-DDAH1 axis in ovarian apoptosis of polycystic ovary syndrome.
Topics: Amidohydrolases; Animals; Apoptosis; Arginine; Dehydroepiandrosterone; Female; Humans; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Signal Transduction | 2023 |
Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome.
Topics: Amidohydrolases; Arginine; Argininosuccinate Lyase; Cationic Amino Acid Transporter 1; Female; Humans; Hydrogen Peroxide; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Oxidation-Reduction; Polycystic Ovary Syndrome; Protein-Arginine N-Methyltransferases; Repressor Proteins | 2017 |
Association between arginase-containing platelet-derived microparticles and altered plasma arginine metabolism in polycystic ovary syndrome.
Topics: Adult; Arginase; Arginine; Blood Platelets; Case-Control Studies; Cell-Derived Microparticles; Female; Humans; Ornithine; Polycystic Ovary Syndrome; Young Adult | 2019 |
Premature aging of cardiovascular/platelet function in polycystic ovarian syndrome.
Topics: Adult; Aging, Premature; Analysis of Variance; Arginine; Atherosclerosis; Biomarkers; C-Reactive Protein; Case-Control Studies; Endothelium, Vascular; Female; Humans; Middle Aged; Nitric Oxide; Platelet Aggregation; Polycystic Ovary Syndrome; Pulse Wave Analysis; Risk Factors | 2013 |
Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2014 |
Endothelial dysfunction and insulin resistance in young women with polycystic ovarian syndrome.
Topics: Adult; Arginine; Body Mass Index; Endothelium, Vascular; Female; Humans; Insulin Resistance; Nitric Oxide; Polycystic Ovary Syndrome; Young Adult | 2014 |
Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
Topics: Adenosine Diphosphate; Adult; Albuterol; Arginine; Body Composition; C-Reactive Protein; Cohort Studies; Endothelial Cells; Endothelium, Vascular; Female; Humans; Inflammation Mediators; Malondialdehyde; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Obesity; Oxidative Stress; Platelet Aggregation; Platelet Function Tests; Polycystic Ovary Syndrome; Stem Cells; Time Factors; Vasodilator Agents | 2009 |
Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters.
Topics: Adolescent; Adult; Arginine; Energy Metabolism; Female; Humans; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Tunica Intima; Tunica Media; Ultrasonography; Young Adult | 2010 |
Criteria for the polycystic ovary syndrome.
Topics: Arginine; Female; Humans; Insulin Resistance; Polycystic Ovary Syndrome; Reference Values; Tunica Intima; Tunica Media | 2009 |
Asymmetric dimethylorginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome.
Topics: Arginine; Carotid Arteries; Female; Humans; Hyperhomocysteinemia; Obesity; Polycystic Ovary Syndrome; Reference Values; Tunica Intima; Tunica Media | 2009 |
Prolonged treatment with N-acetylcysteine and L-arginine restores gonadal function in patients with polycystic ovary syndrome.
Topics: Acetylcysteine; Adolescent; Adult; Amenorrhea; Arginine; Female; Humans; Menstruation; Oligomenorrhea; Ovary; Polycystic Ovary Syndrome; Treatment Outcome | 2009 |
Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?
Topics: Adult; Amino Acid Substitution; Arginine; Aspartic Acid; Case-Control Studies; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Glycine; Greece; Humans; Insulin Receptor Substrate Proteins; Polycystic Ovary Syndrome; Polymorphism, Genetic; Young Adult | 2010 |
Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Female; Hormones; Humans; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2011 |
Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.
Topics: Adult; Arginine; Aryldialkylphosphatase; Biomarkers; Blood Flow Velocity; Brachial Artery; Case-Control Studies; Endothelium, Vascular; Female; Hormones; Humans; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Ultrasonography; Vasodilation; Young Adult | 2011 |
A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro.
Topics: Adult; Androstenedione; Arginine; Aromatase; Case-Control Studies; China; Cysteine; DNA Fingerprinting; Estrogens; Estrone; Female; Genotype; HEK293 Cells; Humans; Mutation; Plasmids; Polycystic Ovary Syndrome; Polymorphism, Genetic; Risk Factors; Transfection | 2011 |
Association of TRB3 Q84R polymorphism with polycystic ovary syndrome in Chinese women.
Topics: Adolescent; Adult; Amino Acid Substitution; Arginine; Asian People; Blood Glucose; Case-Control Studies; Cell Cycle Proteins; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Glutamic Acid; Humans; Obesity; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Repressor Proteins; Young Adult | 2011 |
Vascular function in the diagnostic categories of polycystic ovary syndrome.
Topics: Adult; Arginine; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Insulin Resistance; Overweight; Phenotype; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Vascular Resistance | 2011 |
Symmetric dimethylarginine (SDMA) is raised in women with polycystic ovary syndrome: a pilot study.
Topics: Adult; Androgens; Anthropometry; Arginine; Case-Control Studies; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Insulin; Kidney; Pilot Projects; Polycystic Ovary Syndrome; Young Adult | 2011 |
Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in southwest Chinese women.
Topics: Adolescent; Adult; Arginine; Aryldialkylphosphatase; Asian People; Case-Control Studies; Female; Genetic Association Studies; Glutamine; Humans; Leucine; Methionine; Middle Aged; Polycystic Ovary Syndrome; Polymorphism, Genetic; Young Adult | 2012 |
Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adolescent; Adult; Arginine; Aryldialkylphosphatase; Body Mass Index; Case-Control Studies; Female; Humans; Obesity; Polycystic Ovary Syndrome; Young Adult | 2012 |
Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome.
Topics: Apelin; Arginine; Body Mass Index; Case-Control Studies; Female; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Polycystic Ovary Syndrome; Tumor Necrosis Factor-alpha; Young Adult | 2012 |
Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Intercellular Adhesion Molecule-1; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Vascular Cell Adhesion Molecule-1; Waist Circumference; Weight Loss | 2012 |
Amino acid turnover by human oocytes is influenced by gamete developmental competence, patient characteristics and gonadotrophin treatment.
Topics: Age Factors; Alanine; Amino Acids; Arginine; Chorionic Gonadotropin; Chromatography, High Pressure Liquid; Female; Follicle Stimulating Hormone; Glutamic Acid; Glutamine; Gonadotropins; Humans; Infertility, Female; Isoleucine; Kinetics; Lysine; Metaphase; Oocytes; Ovulation Induction; Polycystic Ovary Syndrome; Serine; Valine | 2013 |
Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.
Topics: Androgens; Arginine; Exons; Female; Genotype; Humans; Hyperandrogenism; Introns; Italy; Linear Models; Methionine; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type II; Solubility; Spain | 2002 |
GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adaptor Proteins, Signal Transducing; Adult; Arginine; Blood Proteins; Calcium-Binding Proteins; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Intercellular Signaling Peptides and Proteins; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Progesterone; Prolactin; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Insulin secretion in women who have polycystic ovary syndrome and carry the Gly972Arg variant of insulin receptor substrate-1 in response to a high-glycemic or low-glycemic carbohydrate load.
Topics: Adolescent; Adult; Amino Acid Substitution; Area Under Curve; Arginine; Blood Glucose; Chile; Codon; Female; Glucose Tolerance Test; Glycemic Index; Glycine; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulin Secretion; Phosphoproteins; Polycystic Ovary Syndrome; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors | 2004 |
The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome.
Topics: Adult; Androgens; Arginine; Female; Glycine; Humans; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Metformin; Phosphoproteins; Polycystic Ovary Syndrome; Polymorphism, Genetic; Steroids | 2005 |
Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism.
Topics: Adolescent; Adult; Alanine; Amino Acid Substitution; Arginine; Diabetes Mellitus; Female; Glucose Intolerance; Glucose Metabolism Disorders; Glucose Tolerance Test; Glycine; Humans; Insulin Receptor Substrate Proteins; Insulin Resistance; Phosphoproteins; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Proline; Prospective Studies; Taiwan | 2006 |
Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
Topics: Adolescent; Apolipoproteins B; Arginine; Biomarkers; Case-Control Studies; Cholesterol; Cholesterol, LDL; Dyslipidemias; Female; Humans; Leptin; Lipoprotein(a); Lipoproteins, LDL; Lipoproteins, VLDL; Multivariate Analysis; Obesity; Polycystic Ovary Syndrome; Triglycerides | 2007 |
Family history of diabetes mellitus determines insulin sensitivity and beta cell function in polycystic ovary syndrome.
Topics: Adult; Anthropometry; Arginine; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon-Secreting Cells; Glucose Clamp Technique; Homeostasis; Hormones; Humans; Insulin Resistance; Insulin-Secreting Cells; Polycystic Ovary Syndrome | 2008 |
Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
Topics: Adult; Androgens; Arginine; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, LDL; Cross-Sectional Studies; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Statistics, Nonparametric; Triglycerides; Waist-Hip Ratio | 2008 |
Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality.
Topics: Arginine; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Risk Factors | 2008 |
No association between common Gly972Arg variant of the insulin receptor substrate-1 and polycystic ovary syndrome in Southern Chilean women.
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Arginine; Case-Control Studies; Chile; Female; Gene Frequency; Genotype; Glycine; Humans; Insulin Receptor Substrate Proteins; Middle Aged; Polycystic Ovary Syndrome | 2008 |
Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS).
Topics: Adult; Androgens; Arginine; Body Mass Index; Case-Control Studies; Contraceptives, Oral; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadotropins; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Time Factors | 2008 |